Cargando…
Tumor treating fields increases membrane permeability in glioblastoma cells
Glioblastoma is the most common yet most lethal of primary brain cancers with a one-year post-diagnosis survival rate of 65% and a five-year survival rate of barely 5%. Recently the U.S. Food and Drug Administration approved a novel fourth approach (in addition to surgery, radiation therapy, and che...
Autores principales: | Chang, Edwin, Patel, Chirag B., Pohling, Christoph, Young, Caroline, Song, Jonathan, Flores, Thomas Anthony, Zeng, Yitian, Joubert, Lydia-Marie, Arami, Hamed, Natarajan, Arutselvan, Sinclair, Robert, Gambhir, Sanjiv S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281619/ https://www.ncbi.nlm.nih.gov/pubmed/30534421 http://dx.doi.org/10.1038/s41420-018-0130-x |
Ejemplares similares
-
Dosimetry Prediction for Clinical Translation of (64)Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression
por: Natarajan, Arutselvan, et al.
Publicado: (2018) -
Permeabilizing Cell Membranes with Electric Fields
por: Aguilar, Alondra A., et al.
Publicado: (2021) -
Multiscale Framework for Imaging Radiolabeled Therapeutics
por: Natarajan, Arutselvan, et al.
Publicado: (2015) -
Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [(18)F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression
por: Patel, Chirag B., et al.
Publicado: (2020) -
Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements
por: Habte, Frezghi, et al.
Publicado: (2018)